Objectives We hypothesized that percutaneous transluminal coronary angioplasty performed on coronary stenoses that have demonstrated rapid angiographic progression would be associated with a high risk of restenosis.
Introduction
High rates of restenosis have been documented after percutaneous transluminal coronary angioplasty of unstable lesions' 1 -2] . We have recently shown that when a stable and an unstable lesion were dilated during the same procedure, the restenosis rate was twice as great at the unstable site 131 . Other than unstable lesions, another lesion subgroup, in whom lesion recurrence is rapid after a successful initial angioplasty, is associated with a high recurrence rate 14 "* 1 . While unstable lesions are associated with plaque rupture and thrombus formation' 7 " 91 , rapidly recurring stenoses after angioplasty are likely to be related to smooth muscle cell proliferation and migration, and to excessive synthesis of extracellular matrix' 101 . Taken together, these studies suggest that the 'activity' of the plaque at the time of angioplasty may be an important factor determining the risk of restenosis. We hypothesized that percutaneous transluminal coronary angioplasty performed at coronary stenoses that have demonstrated rapid angiographic progression would be associated with a high risk of restenosis. We thus analysed the mid-term angiographic outcome when percutaneous transluminal coronary angioplasty is performed at such lesions. We compared, using quantitative coronary angiography, the changes in minimal lumen diameter from angioplasty to follow-up in patients in whom dilatation was carried out in rapidly progressive stenoses and in stenoses that had not progressed.
Methods

Patients
In our institution, all patients are asked to return for systematic repeat angiography 6 months after successful angioplasty. Between January 1986 and December 1992, 3871 patients underwent a successful percutaneous transluminal coronary angioplasty in our institution. Systematic angiographic follow-up was performed in 73%. From this population, we identified 89 consecutive patients who at their control angiogram did not have restenosis but underwent successful balloon angioplasty of another lesion that had not previously been treated by angioplasty. Angiographic follow-up was performed in 86 (96%) of these patients 78 ± 3-8 months later. The angiographic outcome after angioplasty of these 86 lesions, divided into two groups -those that had demonstrated angiographic progression, and those that had not progressed -is the subject of this report.
Procedure and definitions
Angioplasty was performed according to the standard technique in our laboratory, as previously described' 61 . The procedure was considered successful when the residual lumen narrowing in the dilated segment was <50% immediately after angioplasty, and when there was no major complication (myocardial infarction, need for bypass surgery or death). Balloon size was chosen to approximate the diameter of the adjacent normal vessel segment. During the period of this study, the choice of the inflation pressure was at the discretion of the physician performing angioplasty. All clinical and procedural data were prospectively entered into a computerized data base at the time of angioplasty. Unstable angina was defined as episodes of chest pain at rest within the 48 h immediately preceding coronary angioplasty, with diagnostic electrocardiographic changes.
Angiographic analysis
Lesions were classified as rapidly progressive or stable based on a comparison of quantitative angiographic measurements in the angiogram obtained at the time of angioplasty and in the angiogram performed 7-7 ± 3-3 months earlier (at the time of the previous intervention at a different site). The lesions were considered to have progressed if the minimal lumen diameter had decreased by 0-4 mm in the interval between the two angiograms. Lesions that showed a decrease of <;0-4 mm were considered stable. The cut-off value dividing the rapid progression group from the stable group is derived from variability (standard deviation of repeat measurements (0-2 mm) of the same site taken from separate catheterization sessions using our quantitative angiographic system 1 " 1 ). Twice the variability represents a true change in minimal lumen diameter with >95% confidence. A change in minimal lumen diameter of 0-4 mm was considered to be a reliable indicator of stenosis progression.
Quantitative computer-assisted angiographic measurements of the dilated lesion were performed on end-diastolic frames with the CAESAR (Computer Assisted Evaluation of Stenosis And Restenosis) system. A detailed description of this system has been previously reported'
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. We routinely perform angiography in at least two projections, after intracoronary injection of isosorbide dinitrate (2 mg), just before and immediately after angioplasty. These projections are recorded in our database and the follow-up angiogram is performed, after the intracoronary injection of isosorbide dinitrate, in the same projections.
The qualitative analyses were performed independently by two experienced interventional cardiologists. Disagreements were resolved by a further joint reading. Lesions were classified as concentric (symmetrical narrowing, with an identical or almost identical appearance in orthogonal projections) or eccentric (asymmetrical narrowing, with the stenotic lumen appearing to lie within the outer half of the 'normal' lumen of the vessel in at least one projection). The presence of calcification or of thrombus (a discrete intraluminal filling defect) was also noted.
Statistical analysis
Data are presented as mean value ± SD. Comparisons between groups, for continuous data, were made with use of unpaired Student t-tests. Differences between proportions were assessed by chi-square analysis. Procedural and clinical predictors of late loss were determined using stepwise multiple regression. A value of f<005 was considered to indicate statistical significance.
Results
At the 86 lesions studied, the mean change in minimal lumen diameter in the 7-7 ± 3-3 months preceding percutaneous transluminal coronary angioplasty was 0-49 ± 0-44 mm; the distribution of the progression in the 86 patients is shown in Fig. 1 . On the basis of the Eur Heart J, Vol 17, November 1996 strict quantitative angiographic criteria used to define progression, 45 patients were classified as having lesions that had demonstrated significant angiographic progression (rapidly progressive lesions) whereas 41 patients had lesions that had not significantly progressed (stable lesions). The interval between the first angiogram and percutaneous transluminal coronary angioplasty was similar in both groups (stable lesions=7-3 ± 2-3 months; rapidly progressive lesions = 81 ±40 months). Sixty three lesions were located in a different vessel from the original angioplasty; 23 were located in the same vessel, 12 proximal to the previously dilated lesion and 11 distal.
The baseline characteristics before percutaneous transluminal coronary angioplasty are summarized in Table 1 . There were no statistically significant differences between the two groups in age, sex, risk factors for atherosclerosis, extent of coronary artery disease, or treatment since the previous angiogram. The incidence of unstable angina in the rapidly progressive lesion group (20%) was significantly (P<005) higher than that observed in the stable lesion group (5%). The angiographic characteristics of the 86 dilated lesions are shown in Table 2 . Both the location and the morphology of the stenoses were similar in the two groups. Table 3 shows procedural and quantitative angiographic data. The reference diameter did not differ significantly among the groups at any of the four time points studied (the angiogram >6 months before percutaneous transluminal coronary angioplasty, the angiogram just before percutaneous transluminal coronary angioplasty, the angiogram just after percutaneous transluminal coronary angioplasty, and the follow-up angiogram). On the first angiogram, the minimal lumen diameter was significantly greater in the rapidly progressive lesion group (1-59 ±0-48 mm vs 1-18 ±0-36 mm; P<00001). By definition, stenosis progression (between the first angiogram >6 months before percutaneous transluminal coronary angioplasty and the angiogram just before percutaneous transluminal coronary angioplasty) was significantly more marked in the rapidly progressive lesion group (0-81 ± 033 mm) than in the stable lesion group (013±0-23 mm; /><00001). As a consequence, stenosis severity before percutaneous transluminal coronary angioplasty was significantly greater in the rapidly progressive lesion group (minimal lumen diameter=079±0-33 mm) than in the stable lesion group (minimal lumen diameter= 1-04 ± 028 mm; / > <00005). The acute gain during percutaneous transluminal coronary angioplasty (082 ± 0-34) was, however, significantly (P=005) greater in the rapidly progressive lesion group than in the stable lesion group (0-67 ± 0-29) resulting in a similar minimal lumen diameter in both groups immediately after the procedure. Maximal inflation pressure was significantly (P<005) lower in the rapidly progressive lesion group; other procedural variables were similar in the two groups. Late luminal loss during follow-up did not differ statistically between groups (0-31 mm) and the minimal lumen diameter at follow-up was also similar (stable lesion group = 1-40 ± 0-48 mm; rapidly progressive lesion group= 1 -30 ± 059 mm). The loss index (late loss divided by acute gain) was also similar in both groups (0-45 ± 0-52 in the stable lesion group, 037 ± 076 in the rapidly progressive lesion group; / > =ns). Figure 2 demonstrates that there was no relationship between the rate of progression of the stenosis prior to percutaneous transluminal coronary angioplasty expressed as a continuous variable and the late loss after percutaneous transluminal coronary angioplasty in the 86 patients.
Clinical, angiographic (before and after percutaneous transluminal coronary angioplasty), and procedural variables listed in Tables 1-3 were included in a multivariate model to determine independent predictors of late loss. Acute gain was the only determinant of late loss in the rapidly progressive lesion group, while no determinants were detected in the stable lesion group. Figure 3 illustrates the relationship between acute gain and late in the two groups. A strong correlation was observed in the stable lesion group (r = 0-61; / > <00001); by contrast, there was no relationship between these two variables in the rapidly progressive lesion group (r=0-20; f=019).
Finally, we performed a subgroup analysis to determine whether the fact that there was a greater proportion of patients with unstable angina in the rapidly progressive lesion group might have influenced angioplasty. Our database identified patients with lesions that had demonstrated significant angiographic progression over a short period.
Pathological and angiographic studies show that an increase in lesion severity may be associated with unstable angina and myocardial infarction but probably often occurs without clinical consequences'
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. Progression of coronary stenoses is a complex process involving lipid accumulation, cell proliferation, extracellular matrix synthesis, and plaque rupture with subsequent thrombus formation and incorporation 116 ' 171 . In the present study, 80% of the patients who had rapid progression did not have unstable symptoms at the time of angioplasty; this finding is in agreement with previous studies that have suggested that most fissures probably reseal with incorporation of thrombus without producing clinical symptoms 17 '' 61 . We found no differences in the incidence of angiographically visible thrombus between rapidly progressive stenoses and stable stenoses. This is probably related to the low sensitivity of angiography for the detection of intracoronary thrombus' 18 ' 191 ; alternate endovascular imaging techniques such as coronary angioscopy'
18 " 201 or intravascular ultrasound' 211 would provide more precise morphological information on rapidly progressive stenoses. Similarly, directional atherectomy would allow histological examination and thus a better understanding of the mechanisms leading to rapid progression. In the present study, a significantly lower maximum inflation pressure was used for dilatation of rapidly progressive stenoses; this may indicate that rapidly progressive lesions are more compliant than stable lesions. the results. The progression from the first angiogram to percutaneous transluminal coronary angioplasty was similar in patients with (n = 9; 0-80 ± 0-22 mm) and without (n = 36; 081 ± 0-36 mm) unstable angina. The acute result after percutaneous transluminal coronary angioplasty was also similar (minimal lumen diameter post percutaneous transluminal coronary angioplasty = 1 62 ± 0-36 mm in those with unstable angina compared to 1-60 ±0-37 mm in those with stable angina). There was a trend towards a higher late loss in patients with unstable angina (0-50 ±037 mm vs 0-26 ±052 mm) that was not statistically significant.
Discussion
Rapidly progressive stenoses
Although the progression/regression of coronary stenoses over relatively long periods of time (2 to 3 years) has been well described' 13 ' 151 , the occurrence of rapid progression is more difficult to investigate. In our institution, we perform systematic angiographic follow-up after successful percutaneous transluminal coronary
Six-month angiographic follow-up
The specific aim of this study was to analyse restenosis after percutaneous transluminal coronary angioplasty of rapidly progressive stenoses. Our results clearly show that rapid disease progression prior to percutaneous transluminal coronary angioplasty is not a risk factor for restenosis. The late loss and loss index (normalized for the acute gain which was higher in the rapidly progressive lesion group) were similar in both groups.
Previous studies suggest that the 'activity' of the plaque at the time of angioplasty may be an important factor determining the risk of restenosis. High rates of restenosis have been reported in unstable angina and after angioplasty of infarct-related lesions' . Lesions that recur rapidly after angioplasty are also associated with a high rate of recurrence when again treated by percutaneous transluminal coronary angioplasty 14^1 . The exact mechanisms explaining this higher propensity to restenosis of such 'active' lesions are unknown but may be related to the composition of the lesion prior to percutaneous transluminal coronary angioplasty. The presence of already activated smooth muscle cells in the lesion has been demonstrated to be a strong predictor of restenosis after directional atherectomy 1231 ; platelet Eur Heart J, Vol. 17, November 1996 aggregation' 24 ' or thrombus formation 1251 before angioplasty, such as occur at unstable lesions, and which may also increase the response of smooth muscle cells to injury; finally, the presence of a thrombus prior to percutaneous transluminal coronary angioplasty of unstable plaques may also increase restenosis by predisposing the vessel to thrombotic occlusion' 22 ', an event that is relatively rare after percutaneous transluminal coronary angioplasty at stable lesions' 26 '. A plausible explanation for the perhaps surprising observation that rapidly progressive and stable lesions have a similar propensity to restenosis is that the time interval since the rapid growth of the plaque has been long enough to allow the lesion to stabilize and to be less susceptible to restenosis. Although we observed an impressive mean progression of rapidly progressive stenoses (0-81 ±033 mm) over a relatively short period of time (7-7 ± 3-3 months), the absence of severe symptoms in 80% of these patients makes it impossible to determine when such progression occurred; a significant proportion of these lesions may have undergone rapid progression weeks or months before angioplasty. The time interval after which an unstable lesion would become less susceptible to angiographic restenosis has never been specifically investigated but, in one study' 271 , the recurrence of angina in the months following the procedure was shown to be lower for patients with unstable angina who were medically treated and stabilized for 2 weeks before undergoing percutaneous transluminal coronary angioplasty. The subgroup analysis performed in the rapid progression group and showing a late loss twice as high in patients with unstable angina is also in agreement with this hypothesis.
Although the recurrence rate is the same in both groups, the mechanism(s) of restenosis are not necessarily similar. Numerous studies on restenosis have demonstrated that the most powerful determinant of late loss during follow-up is the acute gain during the procedure' 28 '. The very significant relationship between acute gain and late loss in our control group with stable atherosclerosis is in agreement with these previous reports. The usual explanation for this finding is that a high acute gain is associated with a high degree of wall injury and consequently with an exacerbated restenotic process. Despite a similar number of patients, we were not able to demonstrate any relationship between acute gain and late loss at angiographically rapidly progressive lesions; it is again conceivable that the explanation may be related to the composition of the lesions in the rapid progression group. When percutaneous transluminal coronary angioplasty is performed for stable lesions, a high acute gain is probably obtained at the expense of a high degree of stretch and injury to the fibrotic plaque and to the vessel wall; by contrast, when percutaneous transluminal coronary angioplasty is performed for rapidly progressive lesions, it is plausible that a high acute gain can be obtained with less injury by remodelling the soft components of the plaque. Whatever the explanations for this finding may be, the absence of a relationship between acute gain and late loss after percutaneous transluminal coronary angioplasty of rapidly progressive stenoses suggests that the restenotic process observed in this group of patients might be qualitatively different from that observed in patients with stable lesions.
Study limitations
This was a retrospective study. However, the patients were a consecutive group who underwent percutaneous transluminal coronary angioplasty in an institution where the probability that a patient undergoes follow-up angiography is less dependent on symptomatic status after angioplasty. The high rate of angiographic follow-up (96%) coupled with the use of quantitative angiography, allowed an objective assessment of the angiographic probability of restenosis. The strict study criteria has resulted in the inclusion of too few patients to conclusively state that there are no differences in the restenosis rate between rapidly progressive lesions and stable lesions. The data presented here, however, suggest that, if such a difference exists, it would be unlikely to be of clinical significance. Finally, this is an angiographic study; in the future, coronary angioscopy and intravascular ultrasound should give us an opportunity to study more precisely the impact of plaque morphology on restenosis. However, it is very likely that, in clinical practice, coronary angiography will remain the technique of choice for determining the indications for, and assessing the mid-term results of, percutaneous transluminal coronary angioplasty.
Clinical implications
It has been shown that patients whose coronary disease has recently progressed are at higher risk for future coronary events than are patients whose lesions have not changed' 29 ' . Whether revascularization will improve the outcome of recent progressors is not known specifically, but the acceptable rate of restenosis observed in the present study shows that percutaneous transluminal coronary angioplasty is a reasonable therapeutic option for these patients.
